N-Glycosylation of 2,3-Dideoxyfuranose Derivatives Having Difluoro-methylene-phosphonate and -phosphonothioate Functionality at the 3α-Position

Abstract

TiCl₄-Mediated N-glycosylation of 2,3-dideoxyribofunanosides having a difluoromethylene-phosphonate or -phosphonothioate functional group at the 3α-position with silylated pyrimidines was examined. The phosphonate functional was a good directing group to induce α-N-glycosylation for α-N ³-pyrimidine-nucleotide analogue 13 in high diastereoselectivity. The phosphonothioate was an effective functional group to give β-N ¹-pyrimidine-nucleotide analogues 18a-c with good diastereoselectivity. The nucleotide analogue 18a was transformed to the difluoromethylenephosphonate analogue 20 of thymidine-3¢-phosphate by oxidation with MCPBA, followed by aqueous work-up.

nucleotide analogues - N-glycosylations - neighbouring-group effects - phosphorus - fluorine

References

<A NAME="RU05502ST-1A">1a</A> Norbeck DW. Ann. Rep. Med. Chem.  1990,  25:  149 

<A NAME="RU05502ST-1B">1b</A> Nucleoside and Nucleotides as Antitumor and Antiviral Agents   Chu CK. Baker DC. Plenum Press; New York: 1993. 

<A NAME="RU05502ST-2">2</A> Engel R. Chem. Rev.  1977,  77:  349 

<A NAME="RU05502ST-3A">3a</A> Albrecht HP. Jones GH. Moffatt JG. J. Am. Chem. Soc.  1970,  92:  5510 

<A NAME="RU05502ST-3B">3b</A> Morr M. Ernst L. Grotjahn L. Z. Naturforsch., B: Chem. Sci.  1983,  38:  1665 

<A NAME="RU05502ST-3C">3c</A> Albrecht HP. Jones G. Moffatt JG. Tetrahedron  1984,  40:  79 

<A NAME="RU05502ST-3D">3d</A> Morr M. Ernst L. Schomburg D. Liebigs Ann. Chem.  1991,  615 

<A NAME="RU05502ST-3E">3e</A> Morr M. Ernst L. Liebigs Ann. Chem.  1993,  1205 

<A NAME="RU05502ST-4A">4a</A> Blackburn GM. Chem. Ind.  1981,  134 

<A NAME="RU05502ST-4B">4b</A> Chamber RD. O’Hagan D. Lamount RB. Jain SC. J. Chem. Soc., Chem. Commun.  1990,  1053 

<A NAME="RU05502ST-4C">4c</A> O’Hagan D. Rzepa HS. Chem. Commun.  1997,  645 ; and the references cited therein

For recent leading references, see

<A NAME="RU05502ST-5A">5a</A> Burke TR. Ye B. Yan X. Wang S. Jia Z. Chen L. Zhang Z.-Y. Barford D. Biochemistry  1996,  35:  15989 

<A NAME="RU05502ST-5B">5b</A> Jia Z. Ye Q. Dinaut AN. Wang Q. Waddleton D. Payette P. Ramachandran C. Kennedy B. Hum G. Taylor SD. J. Med. Chem.  2001,  44:  4584 

<A NAME="RU05502ST-5C">5c</A> Yokomatsu T. Murano T. Umesue I. Soeda S. Shimeno H. Shibuya S. Bioorg. Med. Chem. Lett.  1999,  9:  529 

<A NAME="RU05502ST-5D">5d</A> Halazy S. Ehrhard A. Eggenspiller A. Berges-Gross V. Danzin C. Tetrahedron  1996,  52:  177 

<A NAME="RU05502ST-5E">5e</A> Yokomatsu T. Hayakawa Y. Kihara T. Koyanagi S. Soeda S. Shimeno H. Shibuya S. Bioorg. Med. Chem.  2000,  8:  2571 

<A NAME="RU05502ST-5F">5f</A> Yokomatsu T. Takechi H. Akiyama T. Shibuya S. Kominato T. Soeda S. Shimeno H. Bioorg. Med. Chem. Lett.  2001,  11:  1277 

<A NAME="RU05502ST-6A">6a</A> Blackburn GM. Guo M.-J. Tetrahedron Lett.  1993,  34:  149 

<A NAME="RU05502ST-6B">6b</A> Matulic-Adamic J. Usman N. Tetrahedron Lett.  1994,  35:  7193 

<A NAME="RU05502ST-6C">6c</A> Matulic-Adamic J. Haeberli P. Usman N. J. Org. Chem.  1995,  60:  2563 

<A NAME="RU05502ST-7A">7a</A> Lequeux TP. Percy JM. Synlett  1995,  361 

<A NAME="RU05502ST-7B">7b</A> Butt AH. Percy JM. Spencer NS. Chem. Commun.  2000,  1691 

<A NAME="RU05502ST-8A">8a</A> Yokomatsu T. Sada T. Shimizu T. Shibuya S. Tetrahedron Lett.  1998,  39:  6299 

<A NAME="RU05502ST-8B">8b</A> Yokomatsu T. Sada T. Shimizu T. Shibuya S. Heterocycles  2000,  52:  515 

Reviews for N-glycosylation in the synthesis of nucleosides and nucleotides:

<A NAME="RU05502ST-9A">9a</A> Vorbüggen H. Acc. Chem. Res.  1995,  28:  509 

<A NAME="RU05502ST-9B">9b</A> Wilson LJ. Hager MW. El-Kattan YA. Liotta DC. Synthesis  1995,  1465 

<A NAME="RU05502ST-9C">9c</A> Vorbrüggen H. Ruh-Pohlenz C. Org. React.  2000,  55:  1 

<A NAME="RU05502ST-10A">10a</A> Martin SF. Dean DW. Wagman AS. Tetrahedron Lett.  1992,  33:  1839 

<A NAME="RU05502ST-10B">10b</A> Berkowitz DB. Eggen M. Shen Q. Shoemarker R. J. Org. Chem.  1996,  61:  4666 

<A NAME="RU05502ST-11">11</A>

Spectroscopic data for selected new compounds:
Compound 9: [α]_D ²⁰ +13.8 (c 1.0, CHCl₃). ¹H NMR (400 MHz, CDCl₃): δ = 4.90-4.83 (1 H, m), 4.38-4.23 (4 H, m), 4.00 (1 H, dd, J = 2.6, 12.5 Hz), 3.72 (1 H, dd, J = 2.9, 12.5 Hz), 3.40-3.22 (1 H, m), 2.85 (2 H, d, J = 8.4 Hz), 2.56 (1 H, br s), 1.40 (6 H, t, J = 7.1 Hz). ¹³C NMR (100 MHz, CDCl₃): δ = 175.1, 119.1 (dt, J _CP = 215.4 Hz, J _CF = 263.0 Hz), 78.6 (d, J _CP = 4.0 Hz), 65.2 (d, J _CP = 7.1 Hz), 65.0 (d, J _CP = 7.1 Hz), 63.0, 40.1 (dt, J _CP = 15.8 Hz, J _CF = 21.0 Hz), 20.3, 16.0 (d, J _CP = 5.2 Hz). ¹⁹F NMR (376 MHz, CDCl₃, benzo-trifluoride): δ = -54.49 (1 F, dd, J _HF = 4.9 Hz, J _PF = 105.2 Hz), -54.54 (1 F, J _HF = 5.8 Hz, J _PF = 105.2 Hz). ³¹P NMR (162 MHz, CDCl₃): δ = 5.76 (t, J _PF = 105.2 Hz). MS (EI):
m/z = 303 [M⁺ + 1], 285 [M⁺ - OH], 271 [M⁺ - CH₂OH]. IR(film): 3247, 2988, 1789, 1645 cm^-1. Anal. Calcd for C₁₀H₁₇O₆F₂P: C, 39.74; H, 5.67. Found: C, 39.43; H, 5.66.
Compound 13: [α]_D ²⁰ +60.4 (c 1.3, CHCl₃). ¹H NMR (400 MHz, CDCl₃): δ = 9.56 (1 H, d, J = 5.6 Hz), 7.74-7.62 (4 H, m), 7.48-7.31 (6 H, m), 6.91 (1 H, dd, J = 1.1, 5.6 Hz), 6.83 (1 H, t, J = 7.7 Hz), 4.90-4.83 (1 H, m), 4.34-4.19 (4 H, m), 4.02-3.94 (1 H, m), 3.82-3.74 (1 H, m), 3.64-3.45 (1 H, m), 3.02 (1 H, ddd, J = 8.4, 12.4, 12.4 Hz), 2.59-2.48 (1 H, m), 1.89 (3 H, d, J = 1.1 Hz), 1.37 (3 H, t, J = 7.1 Hz), 1.36 (3 H, t, J = 7.1 Hz), 1.07 (9 H, s). ¹³C NMR (100 MHz, CDCl₃):
δ = 163.9, 152.6, 135.6, 135.5, 135.0, 133.4, 133.1, 129.6, 127.6, 120.1 (dt, J _CP = 216.2 Hz, J _CF = 263.7 Hz), 110.3, 83.1, 79.8, 64.7 (d, J _CP = 6.7 Hz), 64.5 (J _CP = 6.9 Hz), 64.1, 42.3 (dt, J _CP = 14.4 Hz, J _CF = 20.7 Hz), 29.9, 26.8, 19.3, 16.4 (d, J _CP = 5.2 Hz), 12.9. ¹⁹F NMR (376 MHz, CDCl₃, benzotrifluoride): δ = -47.1 (1 F, dd, J _FF = 300.9 Hz, J _FP = 105.7 Hz), -58.5 (1 F, ddd, J _FF = 300.9 Hz, J_FP = 111.5 Hz, J _FH = 26.1 Hz). ³¹P NMR (162 MHz, CDCl₃): δ = 6.77 (dd, J _PF = 105.7, 111.5 Hz). MS (EI): m/z = 593 [M⁺ - t-Bu]. HRMS (EI): m/z calcd for C₂₇H₃₂N₂O7F₂PSi [M⁺ - t-Bu]: 593.1697. Found: 593.1697. Anal. Calcd for C₃₁H₄₁N₂O₇F₂PSi: C, 57.22; H, 6.35; N, 4.30. Found: C, 56.61; H, 6.35; N, 4.22.
Compound 18a: [α]_D ²⁰ +30.2 (c 1.3, CHCl₃) for a sample of 78% de. ¹H NMR (400 MHz, CDCl₃): δ = 8.07 (1 H, br s), 7.71-7.62 (4 H, m), 7.49-7.34 (7 H, m), 6.19 (1 H, t, J = 6.8 Hz), 4.46-4.40 (1 H, m), 4.31-4.17 (4 H, m), 4.16-4.08 (1 H, m), 3.84 (1 H, dd, J = 2.4, 11.6 Hz), 3.68-3.50 (1 H, m), 2.82-2.72 (1 H, m), 2.21-2.11 (1 H, m), 1.56-1.53 (3 H, m), 1.36 (32 H, t, J = 7.0 Hz), 1.34 (3 H, t, J = 7.0 Hz), 1.11 (9 H, s). ¹³C NMR (100 MHz, CDCl₃): δ = 163.9, 150.3, 135.5, 135.2, 135.0, 133.1, 132.3, 130.0 (2 carbons), 127.9 (2 carbons), 120.9 (dt, J _CP = 176.5 Hz, J _CF = 268.4 Hz), 111.3, 84.5, 78.9, 64.9 (d, J _CP = 6.7 Hz), 64.5, 41.5 (dt, J _CP = 16.6 Hz, J _CF = 20.4 Hz), 33.1, 26.9, 19.4, 16.1 (d, J _CP = 5.7 Hz), 11.9. ¹⁹F NMR (376 MHz, CDCl₃, benzotrifluoride): δ =
-50.3 (1 F, ddd, J _HF = 13.1 Hz, J _FF = 289.5 Hz, J _FP = 110.6 Hz), -54.7 (1 F, ddd, J _HF = 21.9 Hz, J _FF = 289.5 Hz, J _FP = 107.7 Hz). ³¹P NMR (162 MHz, CDCl₃): δ = 74.9 (dd, J _PF = 107.7 Hz, 110.6 Hz). MS (EI): m/z = 609 [M⁺ - t-Bu], 541 [M⁺ - thymine]. Anal. Calcd for C₃₁H₄₁N₂O₆F₂PSSi: C, 55.84; H, 6.20; N, 4.20. Found: C, 55.65; H, 6.14; N, 4.01.
Compound 20: [α]_D ²⁰ +34.0 (c 1.0, CHCl₃). ¹H NMR (400 MHz, CDCl₃): δ = 8.24 (1 H, br s), 7.71-7.61 (4 H, m), 7.48-7.33 (6 H, m), 6.19 (1 H, t, J = 6.9 Hz), 4.48-4.42 (1 H, m), 4.35-4.21 (4 H, m), 4.16-4.08 (1 H, m), 3.84 (1 H, dd, J = 2.5, 11.6 Hz), 3.46-3.25 (1 H, m), 2.85-2.73 (1 H, m), 2.24-2.12 (1 H, m), 1.54 (3 H, s), 1.38 (6 H, t, J = 7.1 Hz), 1.10 (9 H, s). ¹³C NMR (100 MHz, CDCl₃): δ = 163.9, 150.3, 135.5, 135.4, 135.2, 133.1, 132.3, 130.0 (2 carbons), 127.9 (2 carbons), 119.9 (dt, J _CP = 214.3 Hz, J _CF = 263.3 Hz), 111.3, 84.5, 78.5, 64.9 (d, J _CP = 6.8 Hz), 64.8 (d, J _CP = 7.0 Hz), 64.6, 42.3 (dt, J _CP = 15.0 Hz, J _CF = 20.2 Hz), 32.7, 26.9, 19.4, 16.3 (d, J _CP = 5.2 Hz), 11.9. ¹⁹F NMR (376 MHz, CDCl₃, benzotrifluoride): δ = -51.1 (1 F, ddd, J _HF = 14.5 Hz, J _FF = 302.9 Hz, J _PF = 106.8 Hz), -54.0 (1 F, ddd, J _HF = 21.5 Hz, J _FF = 302.9 Hz, J _PF = 106.8 Hz).
³¹P NMR (162 MHz, CDCl₃): δ = 6.31 (t, J _PF = 106.8 Hz). MS (EI): m/z = 593 [M⁺ - t-Bu]. HRMS (EI): m/z calcd for C₂₇H₃₂N₂O7F₂PSi [M⁺ - t-Bu]: 593.1697. Found: 593.1672.

<A NAME="RU05502ST-12">12</A>

Percy et al. reported that the diol i, in situ prepared stereoselectively from the corresponding olefin by OsO₄-catalyzed dihydroxylation, was not readily cyclized to the cis-lactone ii under the conditions. [7b] They were never able to isolate more than 11% of ii. The results are consistent with our findings (Scheme [7] ).

Scheme 7

<A NAME="RU05502ST-13">13</A>

The 1-ethoxy derivative 16 did not react with T(TMS)₂ in the presence of TiCl₄ at -40 °C and the lactol 15 was recovered in 80% yield.